Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      At 9.51% CAGR, Global Thrombosis Drug Market Size & Share Will Hit US$ 47789 Million by 2028 | Industry Trends, Demand, Growth, Value, Analysis & Forecast Report by Zion Market Research

      Zion Market Research Logo

      News provided by

      Zion Market Research

      Jun 28, 2022, 12:00 ET

      Share this article

      Share this article


      NEW YORK, June 28, 2022 /PRNewswire/ -- As per Zion Market Research study, The global thrombosis drug market is likely to grow from $25,892 million in 2021 to $47,789 million by the end of 2028. The global market is anticipated to show exceptional growth with an impressive CAGR of 9.51% during the forecast period. The report presents comprehensive projections on the growth factors, opportunities, and restraining factors.

      Key Industry Insights & Finding of the Thrombosis Drug Market  Reports:

      • As per the analysis shared by our research analyst, the Thrombosis Drug Market is expected to grow annually at a CAGR of around 9.51 % (2022-2028).
      • Through the primary research, it was established that the Thrombosis Drug Market was valued approximately USD 25892 Million in 2021 and is projected to reach to roughly USD 47789 Million by 2028.
      • North America swipes the largest share in the global thrombosis drug market due to the presence of well-established health infrastructure in the region.
      • The presence of proper reimbursement medical policies is further encouraging people to opt for complete thrombosis treatment.
      • Treating cardiovascular problems with medication is a multifaceted approach, but people are also adopting blood thinner medication as a critical treatment for their problems.

      Zion Market Research published the latest report titled as 'Global Thrombosis Drug Market By Disease Type (Deep Vein Thrombosis, Pulmonary Embolism, And Atrial Fibrillation), By Distribution Channel (Online Pharmacies, Hospital Pharmacies, And Retail Pharmacies), By Drug Class (P2Y12 Platelet Inhibitor, Xa Inhibitor, And Heparin), And By Region - Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2022 – 2028.' into their research database.

      Thrombosis Drug Market : Overview

      Thrombosis drugs are referred to as the ones that inhibit the working of platelets, avoid clot formation, and further inhibit the formation of other new clots. These drugs help prevent myriad conditions like deep vein thrombosis and atrial fibrillation. Such drugs have many side effects like bleeding gums & noses, heavy menstrual periods, vomiting, and bleeding. Thrombosis treatment is used to cure the clots to avoid the blockage of an organ. The drugs adopted in the treatment of thrombosis are also referred to as blood thinners.

      Get a Free Sample Report with All Related Graphs & Charts (with COVID 19 Impact Analysis): https://www.zionmarketresearch.com/sample/thrombosis-drug-market

      Our Free Sample Report Includes:

      • 2022 Updated Report Introduction, Overview, and In-depth industry analysis
      • COVID-19 Pandemic Outbreak Impact Analysis Included
      • 180 + Pages Research Report (Inclusion of Updated Research)
      • Provide Chapter-wise guidance on Request
      • 2022 Updated Regional Analysis with Graphical Representation of Size, Share & Trends
      • Includes Updated List of tables & figures
      • Updated Report Includes Top Market Players with their Business Strategy, Sales Volume, and Revenue Analysis
      • Zion Market Research methodology

      Industry Dynamics:

      Thrombosis Drug Market : Growth Drivers

      • Increasing consumption of tobacco and liquor will drive the growth of the global market.

      As per the report from the World Health Organization, it is found that one in three people is overweight. Such statistics are due to the increasing consumption of tobacco and liquor, which is likely to scale up the risk of obesity. Such a landscape further creates critical hypertension, which causes thrombosis-associated problems. Therefore, it is likely to fuel the growth of the global thrombosis drug market exponentially in the forthcoming years. Another crucial factor fueling the growth of the global market is the growing awareness among people regarding the importance of cardiovascular health. However, treating cardiovascular problems with medication is a multifaceted approach, but people are also adopting blood thinner medication as a critical treatment for their problems. Additionally, a number of manufacturers introduced many anticoagulants which address the issues associated with the prevention of blood clots. Such a market landscape will expand the scope of thrombosis drugs. Simultaneously, there is a spike in the number of cases associated with myocardial problems and coronary heart disease, which is also likely to contribute to the growth of the market.

      Thrombosis Drug Market : Restraints

      • Lack of awareness among patients is likely to spur the growth of the global market.

      Thrombosis is a result of certain cardiovascular problems due to aging, and nowadays, the geriatric population is growing rapidly. But simultaneously, there is a lack of awareness among people regarding the seriousness of thrombosis, which in turn will also hamper the growth of the global market. 

      Directly Purchase a Copy of the Report at https://www.zionmarketresearch.com/buynow/su/thrombosis-drug-market

      Thrombosis Drug Market: Opportunities

      • Increasing geriatric population is likely to open new avenues in the global market.

      Thrombosis is common in the aging population because it is caused due to cardiovascular problems, which are highly found in aged people. Additionally, the growing disposable income of people is further encouraging them to adopt complete and successful treatment, which is likely to expand the scope of the global market.

      Thrombosis Drug Market: Challenges

      • Side effects of thrombosis drugs are a huge challenge in the global market.

      For instance, the common side effect of such drugs is uncontrolled bleeding. Furthermore, anti-clotting medications often cause a stroke. Therefore, such conditions are likely to be a huge challenge in the global market.

      Global Thrombosis Drug Market : Segmentation

      • The global thrombosis drug market can be segmented into disease type, distribution channel, drug class, and region.

      By disease type, the market can be segmented into atrial fibrillation, pulmonary embolism, and deep vein thrombosis.

      By distribution channel, the market can be segmented into retail pharmacies, hospital pharmacies, and online pharmacies.

      By drug class, the market can be segmented into heparin, Xa inhibitor, and P2Y12 platelet inhibitor.

      Get More Insight before Buying at : https://www.zionmarketresearch.com/inquiry/thrombosis-drug-market

      List of Key Players of Thrombosis Drug Market :

      • Pfizer
      • Aspen Pharmacare Holdings Limited
      • Bayer AG
      • AstraZeneca plc
      • Sanofi
      • Johnson & Johnson
      • Bristol-Myers Squibb Company
      • Baxter International Inc.
      • Boehringer Ingelheim GmbH
      • GlaxoSmithKline plc.

      Key questions answered in this report:

      • What are the growth rate forecast and market size for Thrombosis Drug Market ?
      • What are the key driving factors propelling the Thrombosis Drug Market forward?
      • What are the most important companies in the Thrombosis Drug Market Industry?
      • What segments does the Thrombosis Drug Market cover?
      • How can I receive a free copy of the Thrombosis Drug Market sample report and company profiles?

      Report Scope:

      Report Attribute

      Details

      Market size value in 2021

      USD 25892 Million

      Revenue forecast in 2028

      USD 47789 Million

      Growth Rate

      CAGR of almost 9.51 % 2022-2028

      Base Year

      2020

      Historic Years

      2016 - 2021

      Forecast Years

      2022 - 2028

      Segments Covered

      By Product Type, By Application, and By End Use

      Forecast Units

      Value (USD Billion), and Volume (Units)

      Quantitative Units

      Revenue in USD million/billion and CAGR from 2022 to 2028

      Regions Covered

      North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World

      Countries Covered

      U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others

      Companies Covered

      Pfizer, Aspen Pharmacare Holdings Limited, Bayer AG, AstraZeneca plc, Sanofi, Johnson & Johnson, Bristol-Myers Squibb Company, Baxter International Inc., Boehringer Ingelheim GmbH, and GlaxoSmithKline plc.

      Report Coverage

      Market growth drivers, restraints, opportunities, Porter's five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.

      Customization Scope

      Avail customized purchase options to meet your exact research needs.  

      https://www.zionmarketresearch.com/custom/3363

      Free Brochure: https://www.zionmarketresearch.com/requestbrochure/thrombosis-drug-market

      Recent Developments

      • Mylan N.V. revealed that it had signed an agreement to take over Aspen Pharmacare Holdings Ltd. in Europe in September 2020.
      • The Story Brook found that using anticoagulation solution lowers the mortality in severe cases of Covid-19 patients in February 2021.

      Regional Dominance:

      • North America to hold the largest market share.

      North America swipes the largest share in the global thrombosis drug market due to the presence of well-established health infrastructure in the region. Additionally, the presence of proper reimbursement medical policies is further encouraging people to opt for complete thrombosis treatment. Furthermore, the presence of prominent market leaders will also expand the scope of the regional market.

      Global Thrombosis Drug Market  is segmented as follows:

      Thrombosis Drug Market : By Disease Type Outlook (2022-2028)

      • Deep vein thrombosis
      • Pulmonary embolism
      • Atrial fibrillation

      Thrombosis Drug Market : By Distribution Channel Outlook (2022-2028)

      • Online pharmacies
      • Hospital pharmacies
      • Retail pharmacies

      Thrombosis Drug Market : By Drug Class Outlook (2022-2028)

      • P2Y12 platelet inhibitor
      • Xa inhibitor
      • Heparin

      Thrombosis Drug Market : By Region Outlook (2022-2028)

      North America

      • The U.S.
      • Canada

      Europe

      • France
      • The UK
      • Spain
      • Germany
      • Italy
      • Rest of Europe

      Asia Pacific

      • China
      • Japan
      • India
      • South Korea
      • Southeast Asia
      • Rest of Asia Pacific

      Latin America

      • Brazil
      • Mexico
      • Rest of Latin America

      Middle East & Africa

      • GCC
      • South Africa
      • Rest of Middle East & Africa

      Press Release For Thrombosis Drug Market : https://www.zionmarketresearch.com/news/global-thrombosis-drug-market

      Browse Other Related Research Reports from Zion Market Research

      • Pharmaceutical Sterility Testing Market - Global Industry Analysis: The global Pharmaceutical Sterility Testing Market accrued earnings worth approximately 1.2(USD Billion) in 2020 and is predicted to gain revenue of about 2.3 (USD Billion) by 2028, is set to record a CAGR of nearly 11.9% over the period from 2021 to 2028.
      • Respiratory Disorders Treatment Market - Global Industry Analysis: The global Respiratory Disorders Treatment market accrued earnings worth approximately 98.9 (USD Billion) in 2020 and is predicted to gain revenue of about 112.5(USD Billion) by 2028, is set to record a CAGR of nearly 6.1% over the period from 2021 to 2028.
      • Medical Enzyme Technology Market - Global Industry Analysis: The global Medical Enzyme Technology market accrued earnings worth approximately 4.5(USD Billion) in 2020 and is predicted to gain revenue of about 6.7(USD Billion) by 2028, is set to record a CAGR of nearly 6.2% over the period from 2021 to 2028.

      Browse through Zion Market Research's coverage of the Global Pharmaceutical Industry

      Follow Us on: LinkedIn | Twitter | Facebook

      About Us

      Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client's needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

      Contact Us:
      Zion Market Research
      244 Fifth Avenue, Suite N202
      New York, 10001, United States
      Tel: +49-322 210 92714
      USA/Canada Toll Free No.1-855-465-4651
      Email: [email protected]
      Website: https://www.zionmarketresearch.com/
      Blog : https://zmrblog.com/

      Logo: https://mma.prnewswire.com/media/1605489/Zion_Market_Research_Logo.jpg

      SOURCE Zion Market Research

      Modal title

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.